Loading interface...

Diziliv Tablet

Manufactured byIcon Life Sciences
ContainsCinnarizine (20 mg) + Dimenhydrinate (40 mg)
Description

Diziliv Tablet is used for the treatment of vertigo and vestibular disorders, which may cause symptoms such as dizziness, headache, nausea, vomiting, hearing changes, visual disturbances, etc.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now

Side effects

Major & minor side effects for Diziliv Tablet

  • Headache
  • Dry mouth
  • Drowsiness
  • Skin rash
  • Constipation
  • Visual disturbances
  • Weight gain
  • Indigestion
  • Stomach discomfort and pain
  • Excessive sweating
  • Unusual tiredness and weakness
  • Twitching and unusual movement of muscles
  • Excessive salivation
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Muscle stiffness and trembling

Uses of Diziliv Tablet

What is it prescribed for?

  • Vertigo and vestibular disorders
Read More
Concerns

Commonly asked questions

  • Onset of action
    The effect of the medicine can be observed within 15-30 minutes of administration.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as drowsiness and dizziness. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any such symptoms.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to dimenhydrinate, cinnarizine, or any other inactive ingredients present along with the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Driving or Operating machinery

Use of this medicine may cause drowsiness, dizziness, blurred vision or other visual disturbances in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms.

Seizures

This medicine should be used with caution in patients with a known history of seizure disorder due to the increased risk of recurrent seizures. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Prostatic hypertrophy

This medicine should be used with caution in patients with prostatic hypertrophy due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Glaucoma

This medicine should be used with caution in patients with glaucoma due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Depression

Use of this medicine may cause a lack of interest, low mood, sleep disturbances in some patients. It should be administered with caution in patients with an active/past instance of depression.

Liver impairment

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Kidney impairment

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose then the missed dose can be skipped.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as drowsiness and dizziness. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any such symptoms.
Interaction with Medicine

Amitriptyline

Tramadol

Diazepam

Amantadine

Topiramate

Duloxetine

Chlorpromazine

Zonisamide

Disease interactions

Cardiovascular disease

This medicine should be used with caution in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Report any symptoms such as an irregular heart rate, dizziness, fainting, uneasiness, shortness of breath, etc. to the doctor immediately. Close monitoring of vital signs, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Asthma/ COPD

This medicine should be used with caution in patients with a known history of asthma or chronic obstructive pulmonary disease due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Parkinson's disease

This medicine should be used with caution in patients suffering from Parkinson's disease due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions

Skin sensitivity test

Report the use of this medicine to the doctor before a skin sensitivity test. This medicine may interfere with the procedure and may give false-negative results.
Take this medicine exactly advised by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Causes sleepiness

How it works
Cinnarizine inhibits contractions of vascular smooth muscle cells of the inner ear. Dimenhydrinate works by acting on the inner ear to reduce the symptoms of vertigo.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Antivertigo agents

Schedule

Schedule H

Cinnarizine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 17 May 2017]. Available from:

https://www.drugbank.ca/drugs/DB00568

Cinnarizine | C26H28N2 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 17 May 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/1547484

Dimenhydrinate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 6 April 2018]. Available from:

https://www.drugbank.ca/drugs/DB00985

Dimenhydrinate: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 6 April 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a607046.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 13 Aug 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.